Enliven Therapeutics, Inc.

General ticker "ELVN" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $1.0B (TTM average)

Enliven Therapeutics, Inc. follows the US Stock Market performance with the rate: 27.9%.

Estimated limits based on current volatility of 5.3%: low 18.67$, high 20.78$

Factors to consider:

  • Total employees count: 46 as of 2023
  • Price in estimated range
  • Earnings for 9 months up through Q3 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

  • 2024-12-31 to 2025-12-31 estimated range: [12.82$, 35.64$]
  • 2025-12-31 to 2026-12-31 estimated range: [9.41$, 27.45$]

Financial Metrics affecting the ELVN estimates:

  • Negative: with PPE of -12.0 at the end of fiscal year the price was very high
  • Negative: negative Operating income
  • Negative: Operating cash flow per share per price, % of -6.85 <= 0.33
  • Negative: negative Industry operating cash flow (median)
  • Negative: negative Net income
  • Positive: -4.48 < Investing cash flow per share per price, % of -3.37
  • Positive: Shareholder equity ratio, % of 95.11 > 63.39
  • Positive: Interest expense per share per price, % of 0 <= 0.01
  • Positive: Inventory ratio change, % of 0 <= 0

Similar symbols

Short-term ELVN quotes

Long-term ELVN plot with estimates

Financial data

YTD 2022-12-31 2023-12-31 2024-12-31
Operating Revenue $0.00MM $0.00MM $0.00MM
Operating Expenses $38.79MM $83.53MM $104.55MM
Operating Income $-38.79MM $-83.53MM $-104.55MM
Non-Operating Income $1.13MM $11.95MM $15.76MM
R&D Expense $31.02MM $64.57MM $80.78MM
Income(Loss) $-37.66MM $-71.58MM $-88.79MM
Taxes $0.00MM $0.00MM $0.23MM
Profit(Loss)* $-37.66MM $-71.58MM $-89.02MM
Stockholders Equity $-76.83MM $245.91MM $309.85MM
Assets $83.30MM $271.87MM $325.76MM
Operating Cash Flow $-32.08MM $-61.27MM $-73.19MM
Capital expenditure $0.61MM $0.15MM $0.04MM
Investing Cash Flow $-0.61MM $-148.41MM $-36.00MM
Financing Cash Flow $-1.80MM $234.29MM $133.16MM
Earnings Per Share** $-6.03 $-2.01 $-1.89

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.